- Agreement between Framingham Risk Score and United Kingdom Prospective Diabetes Study Risk Engine in Identifying High Coronary Heart Disease Risk in North Indian Population
-
Dipika Bansal, Ramya S. R. Nayakallu, Kapil Gudala, Rajavikram Vyamasuni, Anil Bhansali
-
Diabetes Metab J. 2015;39(4):321-327. Published online July 8, 2015
-
DOI: https://doi.org/10.4093/dmj.2015.39.4.321
-
-
3,567
View
-
33
Download
-
11
Web of Science
-
12
Crossref
-
Abstract
PDFPubReader
- Background
The aim of the study is to evaluate the concurrence between Framingham Risk score (FRS) and United Kingdom Prospective Diabetes Study (UKPDS) risk engine in identifying coronary heart disease (CHD) risk in newly detected diabetes mellitus patients and to explore the characteristics associated with the discrepancy between them. MethodsA cross-sectional study involving 489 subjects newly diagnosed with type 2 diabetes mellitus was conducted. Agreement between FRS and UKPDS in classifying patients as high risk was calculated using kappa statistic. Subjects with discrepant scores between two algorithms were identified and associated variables were determined. ResultsThe FRS identified 20.9% subjects (range, 17.5 to 24.7) as high-risk while UKPDS identified 21.75% (range, 18.3 to 25.5) as high-risk. Discrepancy was observed in 17.9% (range, 14.7 to 21.7) subjects. About 9.4% had high risk by UKPDS but not FRS, and 8.6% had high risk by FRS but not UKPDS. The best agreement was observed at high-risk threshold of 20% for both (κ=0.463). Analysis showed that subjects having high risk on FRS but not UKPDS were elderly females having raised systolic and diastolic blood pressure. Patients with high risk on UKPDS but not FRS were males and have high glycosylated hemoglobin. ConclusionThe FRS and UKPDS (threshold 20%) identified different populations as being at high risk, though the agreement between them was fairly good. The concurrence of a number of factors (e.g., male sex, low high density lipoprotein cholesterol, and smoking) in both algorithms should be regarded as increasing the CHD risk. However, longitudinal follow-up is required to form firm conclusions.
-
Citations
Citations to this article as recorded by
- Endocan is Related to Increased Cardiovascular Risk in Type 2 Diabetes Mellitus Patients
Aleksandra Klisic, Jelena Kotur-Stevuljevic, Ana Ninic Metabolic Syndrome and Related Disorders.2023; 21(7): 362. CrossRef - Estimated risk of cardiovascular events and long-term complications: The projected future of diabetes patients in Delhi from the DEDICOM-II survey
Swapnil Rawat, Ramasheesh Yadav, Siddhi Goyal, Jitender Nagpal Diabetes & Metabolic Syndrome: Clinical Research & Reviews.2023; 17(11): 102880. CrossRef - Cardiovascular Biomarkers and Calculated Cardiovascular Risk in
Orally Treated Type 2 Diabetes Patients: Is There a Link?
Aleksandra Markova, Mihail Boyanov, Deniz Bakalov, Atanas Kundurdjiev, Adelina Tsakova Hormone and Metabolic Research.2021; 53(01): 41. CrossRef - Risk of coronary heart disease and stroke based on United Kingdom prospective diabetes study in type 2 DM patients in Medan
R Amelia, J Harahap, H Wijaya, I I Fujiati IOP Conference Series: Earth and Environmental Science.2021; 912(1): 012081. CrossRef - Cardiovascular/stroke risk prevention: A new machine learning framework integrating carotid ultrasound image-based phenotypes and its harmonics with conventional risk factors
Ankush Jamthikar, Deep Gupta, Narendra N. Khanna, Luca Saba, John R. Laird, Jasjit S. Suri Indian Heart Journal.2020; 72(4): 258. CrossRef - Current Data Regarding the Relationship between Type 2 Diabetes Mellitus and Cardiovascular Risk Factors
Cosmin Mihai Vesa, Loredana Popa, Amorin Remus Popa, Marius Rus, Andreea Atena Zaha, Simona Bungau, Delia Mirela Tit, Raluca Anca Corb Aron, Dana Carmen Zaha Diagnostics.2020; 10(5): 314. CrossRef - Artificial intelligence framework for predictive cardiovascular and stroke risk assessment models: A narrative review of integrated approaches using carotid ultrasound
Ankush D. Jamthikar, Deep Gupta, Luca Saba, Narendra N. Khanna, Klaudija Viskovic, Sophie Mavrogeni, John R. Laird, Naveed Sattar, Amer M. Johri, Gyan Pareek, Martin Miner, Petros P. Sfikakis, Athanasios Protogerou, Vijay Viswanathan, Aditya Sharma, Georg Computers in Biology and Medicine.2020; 126: 104043. CrossRef - Additive and Synergistic Cardiovascular Disease Risk Factors and HIV Disease Markers' Effects on White Matter Microstructure in Virally Suppressed HIV
Maëliss Calon, Kritika Menon, Andrew Carr, Roland G. Henry, Caroline D. Rae, Bruce J. Brew, Lucette A. Cysique JAIDS Journal of Acquired Immune Deficiency Syndromes.2020; 84(5): 543. CrossRef - Performance evaluation of 10-year ultrasound image-based stroke/cardiovascular (CV) risk calculator by comparing against ten conventional CV risk calculators: A diabetic study
Narendra N. Khanna, Ankush D. Jamthikar, Deep Gupta, Andrew Nicolaides, Tadashi Araki, Luca Saba, Elisa Cuadrado-Godia, Aditya Sharma, Tomaz Omerzu, Harman S. Suri, Ajay Gupta, Sophie Mavrogeni, Monika Turk, John R. Laird, Athanasios Protogerou, Petros P. Computers in Biology and Medicine.2019; 105: 125. CrossRef - Cardiovascular risk estimated by UKPDS risk engine algorithm in diabetes
Nebojsa Kavaric, Aleksandra Klisic, Ana Ninic Open Medicine.2018; 13(1): 610. CrossRef - Differential Association of Metabolic Risk Factors with Open Angle Glaucoma according to Obesity in a Korean Population
Hyun-Ah Kim, Kyungdo Han, Yun-Ah Lee, Jin A Choi, Yong-Moon Park Scientific Reports.2016;[Epub] CrossRef - The Association between Diabetic Retinopathy and Framingham Risk Score in Koreans with Type II Diabetes
Da Yeong Kim, Su Jeong Song, Jeong Hun Bae, Cheol-Young Park, Eun-Jung Rhee Journal of the Korean Ophthalmological Society.2016; 57(5): 779. CrossRef
|